NCT02286882View on ClinicalTrials.gov

A Single Oral Dose Study Of PF-06409577 In Healthy Adult Subjects

PHASE1TerminatedINTERVENTIONAL

Enrollment

39

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Healthy

Interventions

DRUG

PF-06409577 or Placebo

PF-06409577or placebo will be administered as an extemporaneously prepared suspension once in each cohort

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT02286882 - A Single Oral Dose Study Of PF-06409577 In Healthy Adult Subjects | Biotech Hunter | Biotech Hunter